# Study of Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)for Treatment of Post Operative Nausea and Vomiting

> **NCT01984931** · PHASE3 · UNKNOWN · sponsor: **CM Chungmu Hospital** · enrollment: 45 (estimated)

## Conditions studied

- Nausea
- Vomiting

## Interventions

- **DRUG:** Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)
- **DRUG:** Metoclopramide hydrochloride monohydrate

## Key facts

- **NCT ID:** NCT01984931
- **Lead sponsor:** CM Chungmu Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2013-11-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01984931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01984931, "Study of Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)for Treatment of Post Operative Nausea and Vomiting". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01984931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*